Joop van den Bergh
Overview
Explore the profile of Joop van den Bergh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
420
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Quintiens J, Manske S, Boyd S, Coudyzer W, Bevers M, Vereecke E, et al.
Bone
. 2025 Mar;
194:117443.
PMID: 40032018
The quantification of bone microarchitecture provides insight into bone health and the effects of disease or treatment, and is therefore highly relevant clinical information. Nonetheless, in vivo quantification of bone...
2.
Rasmussen N, Driessen J, Kvist A, Souverein P, van den Bergh J, Vestergaard P
Bone
. 2023 Nov;
179:116977.
PMID: 38006906
Objective: This study aimed to determine the hazard ratios (HR) for various fracture sites and identify associated risk factors in a cohort of relatively healthy adult people with newly diagnosed...
3.
Rasmussen N, Dal J, Jensen M, Kvist A, van den Bergh J, Hirata R, et al.
Arch Osteoporos
. 2022 Dec;
18(1):6.
PMID: 36482222
Introduction/aim: People with type 1 diabetes (T1D) and type 2 diabetes (T2D) are at risk of falling, but the association with impaired postural control is unclear. Therefore, the aim was...
4.
Geusens P, Appelman-Dijkstra N, Lems W, van den Bergh J
Expert Opin Biol Ther
. 2022 Nov;
23(1):11-19.
PMID: 36440489
Introduction: Romosozumab is a monoclonal antibody that binds to sclerostin (an inhibitor of the Wingless-related integration site (Wnt) signaling pathway). It is a new osteoanabolic drug that simultaneously increases bone...
5.
Geusens P, Appelman-Dijkstra N, Zillikens M, Willems H, Lems W, van den Bergh J
Best Pract Res Clin Rheumatol
. 2022 Jun;
36(3):101759.
PMID: 35729036
In subjects older than 50 years, the presence of clinical risk factors (CRFs) for fractures or a recent fracture is the cornerstone for case finding. In patients who are clinically...
6.
Bliuc D, Tran T, Adachi J, Atkins G, Berger C, van den Bergh J, et al.
J Bone Miner Res
. 2022 Feb;
37(5):1075-1076.
PMID: 35195305
No abstract available.
7.
Veldhuis L, Ridderikhof M, Schinkel M, van den Bergh J, Beudel M, Dormans T, et al.
Emerg Med J
. 2021 Oct;
38(12):901-905.
PMID: 34706897
Objective: Validated clinical risk scores are needed to identify patients with COVID-19 at risk of severe disease and to guide triage decision-making during the COVID-19 pandemic. The objective of the...
8.
Safipour Z, van der Zanden R, van den Bergh J, Janssen P, Vestergaard P, de Vries F, et al.
Osteoporos Int
. 2021 Oct;
33(3):649-658.
PMID: 34601629
Purpose/introduction: The prolonged use of high doses of oral glucocorticoids (GCs), a common treatment in patients with myasthenia gravis (MG), may increase major osteoporotic fracture (MOF) risk. Previous epidemiological studies...
9.
Bliuc D, Tran T, Adachi J, Atkins G, Berger C, van den Bergh J, et al.
J Bone Miner Res
. 2021 Jul;
36(11):2106-2115.
PMID: 34289172
Cognitive decline and osteoporosis often coexist and some evidence suggests a causal link. However, there are no data on the longitudinal relationship between cognitive decline, bone loss and fracture risk,...
10.
Houghton R, van den Bergh J, Law K, Liu Y, de Vries F
Autism Res
. 2021 Jun;
14(8):1800-1814.
PMID: 34080319
Risperidone and aripiprazole, commonly used antipsychotics in children with autism spectrum disorder (ASD), have previously been associated with elevated fracture risk in other populations. The aim of this study was...